Ad is loading...
IDYA
Price
$26.60
Change
+$1.06 (+4.15%)
Updated
Nov 21 closing price
130 days until earnings call
RCKT
Price
$12.79
Change
-$0.25 (-1.92%)
Updated
Nov 21 closing price
104 days until earnings call
Ad is loading...

IDYA vs RCKT

Header iconIDYA vs RCKT Comparison
Open Charts IDYA vs RCKTBanner chart's image
IDEAYA Biosciences
Price$26.60
Change+$1.06 (+4.15%)
Volume$1.78M
CapitalizationN/A
Rocket Pharmaceuticals
Price$12.79
Change-$0.25 (-1.92%)
Volume$1.34M
CapitalizationN/A
IDYA vs RCKT Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IDYA vs. RCKT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and RCKT is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (IDYA: $26.60 vs. RCKT: $12.79)
Brand notoriety: IDYA and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 200% vs. RCKT: 134%
Market capitalization -- IDYA: $2.21B vs. RCKT: $1.17B
IDYA [@Biotechnology] is valued at $2.21B. RCKT’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and RCKT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while RCKT’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • RCKT’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than RCKT.

Price Growth

IDYA (@Biotechnology) experienced а -9.74% price change this week, while RCKT (@Biotechnology) price change was -13.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

IDYA is expected to report earnings on Apr 01, 2025.

RCKT is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($2.21B) has a higher market cap than RCKT($1.17B). IDYA YTD gains are higher at: -25.239 vs. RCKT (-57.324). IDYA has higher annual earnings (EBITDA): -220.54M vs. RCKT (-247.25M). IDYA has more cash in the bank: 920M vs. RCKT (236M). IDYA has less debt than RCKT: IDYA (18.8M) vs RCKT (25.6M). IDYA has higher revenues than RCKT: IDYA (3.92M) vs RCKT (0).
IDYARCKTIDYA / RCKT
Capitalization2.21B1.17B189%
EBITDA-220.54M-247.25M89%
Gain YTD-25.239-57.32444%
P/E RatioN/AN/A-
Revenue3.92M0-
Total Cash920M236M390%
Total Debt18.8M25.6M73%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYARCKT
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 16 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSMLX30.630.52
+1.73%
Principal SmallCap R6
APHNX15.990.11
+0.69%
Artisan Select Equity Institutional
CIICX36.590.04
+0.11%
American Funds Intl Gr and Inc 529C
MSERX10.63N/A
N/A
MassMutual Small Cap Growth Eq R4
IJPTX12.39-0.04
-0.32%
VY® JPMorgan Emerging Markets Equity S2

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with GRI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+4.15%
GRI - IDYA
54%
Loosely correlated
+7.82%
PLRX - IDYA
48%
Loosely correlated
+0.94%
INAB - IDYA
47%
Loosely correlated
-0.47%
ALEC - IDYA
46%
Loosely correlated
+3.44%
ETNB - IDYA
45%
Loosely correlated
+5.01%
More